Literature DB >> 12730534

Quantifying the burden of emotional ill-health amongst patients referred to a specialist rheumatology service.

N L Maiden1, N P Hurst, A Lochhead, A J Carson, M Sharpe.   

Abstract

OBJECTIVES: (1) To determine the prevalence of emotional disorders (DSM IV depression, anxiety and panic disorders) amongst patients referred to a rheumatology out-patient service and the proportion of these detected by the rheumatologist. (2) To test the hypotheses that emotional disorders are associated with (i) broad categories of rheumatological diagnosis (systemic, inflammatory vs non-systemic, non-inflammatory), (ii) female gender, (iii) greater symptom burden and disability and (iv) markers of socio-economic deprivation.
METHODS: A cross-sectional study was made of consecutive newly referred attenders at a hospital-based, regional rheumatology service. Emotional disorders, pain, health status and socio-economic factors were assessed by questionnaire. The letter to the referrer was scrutinized for the rheumatological diagnosis and mention of emotional disorder.
RESULTS: A total of 256 patients were eligible and 203 (79%) participated. The sample was 69% female, had a mean age of 50 yr and 68 patients (33.5%) had one or more emotional disorders. Only a minority were detected. There was no association with type of rheumatological diagnosis. Patients with an emotional disorder were more likely to be female (81 vs 62%; P<0.007), to report more pain (mean Visual Analogue Score 70 vs 50 mm, P<0.001), a greater number of somatic symptoms (median 3 vs 1, P<0.001) and greater disability (median Health Assessment Questionnaire 1.1 vs 0.5, P<0.001). Emotional disorders were also associated with some, but not all, measures of lower social and economic status and life dissatisfaction.
CONCLUSIONS: Emotional disorder is present in one-third of new rheumatology referrals. The course, causation and management of this important component of rheumatological illness merit further attention.

Entities:  

Mesh:

Year:  2003        PMID: 12730534     DOI: 10.1093/rheumatology/keg211

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  6 in total

1.  Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated.

Authors:  Panagiota Anyfanti; Eleni Gavriilaki; Athina Pyrpasopoulou; George Triantafyllou; Areti Triantafyllou; Sofia Chatzimichailidou; Eugenia Gkaliagkousi; Spyros Aslanidis; Stella Douma
Journal:  Clin Rheumatol       Date:  2014-05-25       Impact factor: 2.980

2.  Anxiety, depression, and inflammation after restorative proctocolectomy.

Authors:  Venkata Subhash Gorrepati; Sanjay Yadav; August Stuart; Walter Koltun; Evangelos Messaris; Emmanuelle D Williams; Matthew D Coates
Journal:  Int J Colorectal Dis       Date:  2018-06-29       Impact factor: 2.571

3.  Effect of depression treatment on chronic pain outcomes.

Authors:  Carrie Farmer Teh; Alan M Zaslavsky; Charles F Reynolds; Paul D Cleary
Journal:  Psychosom Med       Date:  2009-10-29       Impact factor: 4.312

4.  Depression and its correlation with in patients pain in the rheumatology service of a Mexican teaching hospital.

Authors:  Antonio Kobayashi-Gutiérrez; Gloria Martinez-Bonilla; Ana Guillaisne Bernard-Medina; Rogelio Troyo-Sanroman; Verónica González-Díaz; Esteban Castro-Contreras; Eduardo Vázquez-Valls; Blanca Miriam Torres-Mendoza
Journal:  Rheumatol Int       Date:  2008-12-27       Impact factor: 2.631

5.  Negative and positive life experiences in patients with psoriatic arthritis.

Authors:  Edita Simonić; Sandra Peternel; Liliana Stojnić-Soša; Ika Rončević-Gržeta; Larisa Prpić-Massari; Dražen Massari; Darinka Periša; Leo Cabrijan; Marija Kaštelan
Journal:  Rheumatol Int       Date:  2012-11-21       Impact factor: 2.631

6.  Identification and Treatment Optimization of Comorbid Depression in Rheumatoid Arthritis.

Authors:  Mellissa H Withers; Louella T Gonzalez; George A Karpouzas
Journal:  Rheumatol Ther       Date:  2017-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.